A New Jersey federal judge has revived a bankrupt Johnson & Johnson talc subsidiary's trade libel claim over a 2020 scientific article linking asbestos in talc to mesothelioma, finding that new evidence and allegations concerning the authenticity of the author's data are enough to survive a motion to dismiss.
U.S. District Judge Georgette Castner on Friday granted Pecos River Talc LLC's motion for relief from judgment and leave to amend its complaint against Dr. Jacqueline Moline, concluding that the company — successor to Johnson & Johnson's talc liabilities — had presented significant new allegations that were unavailable when the court first dismissed the suit.
Central to the ruling was the disclosure of a "key" identifying all 33 individuals whose medical histories formed the basis of Moline's 2020 article in the Journal of Occupational and Environmental Medicine, which asserted that each patient had "no known asbestos exposure other than cosmetic talcum powder."
"The extensiveness of the fraudulent nature of the article demonstrates that Dr. Moline fabricated the data presented in her article," Judge Castner wrote of Pecos River's new evidence, quoting directly from the proposed amended complaint.
That allegation, the court said, if proven, would fall outside the First Amendment protections that shield scientific debate and peer‑reviewed conclusions.
Pecos River argued that the newly revealed identities showed that numerous individuals in the study had documented asbestos exposures unrelated to cosmetic talc and that Moline allegedly knew about the exposures from her work as a plaintiffs' expert in their underlying tort cases. The company contended that the new information fundamentally alters the nature of its claim, shifting it from a dispute over scientific interpretation to an allegation of data fabrication.
The decision marks a dramatic reversal in a case that was dismissed in 2024 and signals that the litigation over the scientific underpinnings of talc‑related cancer claims is far from over.
Moline's 2020 article has been widely cited in talc‑mesothelioma litigation across the country. The study described 33 individuals who allegedly developed mesothelioma despite having "no known asbestos exposure other than cosmetic talcum powder," and concluded that exposure to asbestos‑contaminated talcum powders "can cause mesothelioma." The article has been described as groundbreaking, with widespread influence on litigation involving Johnson & Johnson's Baby Powder and Shower‑to‑Shower products.
Pecos River alleges that the article's central premise was false and that Dr. Moline knew it was false when she published it. The company claims that Dr. Moline's role as a paid expert in more than 200 cosmetic‑talc cases gave her access to deposition transcripts, medical records and other materials showing that many of the individuals had alternative asbestos exposures, information she allegedly omitted from the study.
When the court dismissed the case in 2024, it held that Dr. Moline's statements were nonactionable scientific opinions. Applying the Third Circuit's framework for distinguishing fact from scientific inference, the court concluded that the article's statements were "tentative and subject to revision," and that disputes over the completeness of the data were matters for peer review, not litigation.
But the new evidence, Judge Castner wrote, changed the analysis.
The turning point came in April 2025, when a New York appellate court authorized the deanonymization of the 33 individuals in the study. The resulting "key" confirmed that four individuals previously suspected by Pecos River — Helen Kohr, Stephen Lanzo, Doris Jackson and Valerie Jo Dalis — were indeed among the study subjects. More important, Pecos River alleged that the key revealed at least seven additional individuals who had known asbestos exposures unrelated to cosmetic talc.
One example is Carol Schoeniger, who testified that her husband sanded and applied asbestos‑containing joint compound in their home in the 1960s. Pecos River pointed out that in Schoeniger's underlying litigation, Moline herself identified this as a potential exposure. Yet the 2020 article listed Schoeniger as having no known exposure apart from talc.
Similar discrepancies appeared across multiple individuals, Pecos River claims, arguing that collectively they suggested not mere scientific disagreement but intentional misrepresentation.
Judge Castner emphasized that the new allegations go beyond the court's earlier concerns about omitted variables or interpretive differences. If Pecos River can prove that Moline knowingly misrepresented the subjects' exposure histories, the statements in the article could be treated as verifiably false factual assertions rather than protected scientific conclusions.
The court also noted the relevance of a 2025 decision from the Eastern District of Virginia, LLT Mgmt. LLC v. Emory, which involved a different article related to Moline's asbestos work. That case addressed similar allegations of data manipulation and provided a framework for treating certain scientific representations as potentially factual and actionable. While not binding, the Virginia decision reinforced the idea that allegations of fabrication fell outside the protections afforded to scientific opinion.
Representatives for the parties did not immediately respond to requests for comment Monday.
Pecos River Talc is represented by Peter C. Harvey and Thomas P. Kurland of Patterson Belknap Webb & Tyler LLP, and Matthew L. Bush of Kirkland & Ellis LLP.
Moline is represented by Kevin H. Marino and John D. Tortorella of Marino Tortorella & Boyle PC.
The case is Pecos River Talc LLC f/k/a LTL Management LLC v. Moline, case number 3:23-cv-02990, in the U.S. District Court for the District of New Jersey.
Mar 2
Deal Summary
